Recognized for contributions to developing radiofrequency and plasma medical device technologies

Shenvy said that CEO Kang Sunyoung received the Industrial Service Medal in the Technology Innovation category at the awards ceremony for the '2026 SME Innovation Week' held on November 18 at the Osong Convention Center (OSCO) in Cheongju, North Chungcheong Province. 


Kang was recognized for developing and commercializing energy-based aesthetic medical device technologies, including radiofrequency (RF) and plasma technologies, and for enhancing the technological competitiveness of South Korea's medical device industry.

Shenvy CEO Kang Sunyoung Receives Industrial Service Medal for Technology Innovation View original image

Founded in 1999, Shenvy specializes in aesthetic medical devices. Its radiofrequency medical devices, including 'SUNNY' and 'VIRTUE RF,' have received approval from the U.S. Food and Drug Administration (FDA). In 2018, it developed 'PLADUO,' a dual-plasma medical device that uses nitrogen and argon. It currently exports its products to 96 countries worldwide.



"This medal is an achievement shared by all Shenvy employees, who have worked hard on technology development over many years," Kang said. "We will continue to pursue technological innovation and promote the competitiveness of K-medical devices around the world."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing